Insider trades
Sohanya Roshan Cheng, Chief Officer of Karyopharm Therapeutics KPTI, has filed 0 purchases and 10 sales on the open market. Over the past 12 months that comes to a net sale of $46.4K. The latest trade was on 05/14.
Sohanya Roshan Cheng
EVP & Chief Commercial Officer
- Company
- Karyopharm Therapeutics KPTI
- First filing
- 23/03/02
- Trades
- 22 trades
- Buys / sales
- 0 / 10
- 12-month net buying
- −$46.4K
- Last trade
- 05/14
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 05/14 | 05/15 | 324 sh | $9.50 | $3,078 | −0.3% | |
| Open-market sale | 03/02 | 03/03 | 4,604 sh | $9.41 | $43,323.64 | −4.1% | |
| Open-market sale | 25/09/15 | 25/09/16 | 325 sh | $6.43 | $2,089.75 | −0.9% | |
| Open-market sale | 25/03/04 | 25/03/06 | 3,445 sh | $6.29 | $21,669.05 | −9.1% | |
| Open-market sale | 24/09/04 | 24/09/05 | 5,356 sh | $0.72 | $3,856.32 | −1.3% | |
KPTI | Open-market sale | 24/02/29–24/03/01 | 24/03/04 | 26,949 sh2 trades | $1.18avg. | $31,683.6 | −6.4% |
| Open-market sale | 23/09/01 | 23/09/05 | 7,415 sh | $1.33 | $9,861.95 | −3.5% | |
| Open-market sale10b5-1 plan | 23/06/08 | 23/06/12 | 1,839 sh | $2.35 | $4,321.65 | −0.9% | |
| Open-market sale | 23/03/01 | 23/03/02 | 11,239 sh | $3.03 | $34,054.17 | −5.1% |